Sun Pharmaceuticals
US FDA rescinds approval for Sun Pharma's epilepsy drug Elepsia XR
26 Sep 2015
The US Food and Drug Administration (US FDA) has revoked an earlier approval to Sun Pharma Advanced Research Company Ltd to market its new drug for seizures
Daiichi Sankyo sells entire 9% stake in Sun Pharma for Rs20,420 cr
21 Apr 2015
Daiichi Sankyo said it would make an announcement concerning gains or losses on the sale of Sun Pharma shares when results of operations for the fiscal year ending in March 2015 are announced
Sun, Ranbaxy complete $4-bn merger
24 Mar 2015
On Tuesday, the Reserve Bank of India approved the issue of equity shares of Sun Pharma to non-resident holders of equity shares of Ranbaxy, facilitating the merger through a scheme of arrangement
Sun Pharma’s Dilip Shanghvi pips Mukesh Ambani to become richest Indian
05 Mar 2015
Dilip Shanghvi, who is also the world’s richest pharmaceutical billionaire, added $4.5 billion to his fortune this year, making him fourth-wealthiest in Asia and 37th in the world
Sun Pharma to buy Glaxo’s Australian opiates business
03 Mar 2015
The deal comes as Sun wraps up the last leg of its $ 4-billion proposal to buy troubled generic drugs maker Ranbaxy in India
Suzlon Energy confirms 23% stake sale to Sun’s Shanghvi
14 Feb 2015
Dilip Shanghvi and others on Saturday made an open offer to shareholders of Suzlon Energy immediately after announcing that it would invest Rs1,800 crore in the company
Sun’s Shanghvi reported in talks with Tanti for Suzlon stake
13 Feb 2015
Sun Pharmaceuticals founder Dilip Shanghvi and Tulsi Tanti of Suzlon Energy are in advanced talks for a multi-layer deal to eventually give the pharma baron's family a stake in the debt-laden wind turbine maker
Sun Pharma buyout of Ranbaxy gets conditional US nod
31 Jan 2015
Fearing that the $4-billion deal would be anti-competitive, the FTC has stipulated that Sun sell its interest in a generic anti-bacterial medicine
Sun Pharma, Ranbaxy merger deal gets conditional CCI nod
09 Dec 2014
The CCI has asked the two companies to sell off seven brands with combined sales of less than Rs50 crore and market share of 60 to 80 per cent, which the regulator felt, would adversely affect competition
Sun-Ranbaxy merger: competition panel demands more details
28 Aug 2014
This is probably the first instance where the fair trade watchdog has ordered a public scrutiny of a proposed merger and acquisition deal to ensure compliance to fair trade regulation
AP High Court vacates stay on Ranbaxy-Sun Pharma merger
24 May 2014
The Andhra Pradesh High Court has vacated a stay on the proposed merger of Ranbaxy Laboratories with Sun Pharma over alleged insider trading in Ranbaxy shares ahead of the merger announcement
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "India, Nigeria agree on local currency settlement system")
